S&P 500 Consumer Discretionary Sector SEC Filings — May 05, 2026

USA S&P 500 Consumer Discretionary

17 high priority33 medium priority50 total filings analysed

Executive Summary

Across 50 SEC filings from the USA S&P 500 Consumer Discretionary intelligence stream (primarily retail, automotive, restaurants, hotels, entertainment), Q1 2026 earnings dominate with mixed sentiment: 70% of revenue-reporting companies showed YoY growth averaging +15% (e.g., Shopify +34%, Fabrinet +39%, Life Time Group +11.7%), but 40% faced margin compression averaging -120 bps amid cost pressures (e.g., TransDigm EBITDA margin -140 bps, Fiserv -890 bps). Capital allocation remains shareholder-friendly, with 18 companies announcing/expanding buybacks (total ~$7B incl. TransDigm $905M YTD, DFIN new $150M) and 12 dividend declarations/hikes (e.g., Energy Transfer +3% to $0.3375/unit). M&A/divestitures active in 8 filings (Ferguson 5+ deals, Compass $292.5M sale), supporting deleveraging and growth. Forward guidance largely affirmed/raised (e.g., Energy Transfer EBITDA to $18.2-18.6B, Shopify Q2 high-20s% growth), signaling management conviction despite macro headwinds. Consumer Discretionary outliers shine with resilient demand (First Watch +17% rev, Haverty comp sales +4.3%), positioning for outperformance vs. broader mixed trends. Portfolio implication: overweight growth leaders with strong capital returns; monitor margin trends and Q2 catalysts.

Tracking the trend? Catch up on the prior S&P 500 Consumer Discretionary Sector SEC Filings digest from April 28, 2026.

Investment Signals(12)

  • Q1 adj op earnings +13% YoY to $2.26/share across all segments, $200M excess capital with $194M returned via buybacks/dividends, $413M repurchase auth remaining

  • Q1 sales +3.6% YoY (2.8% organic), gross margin +30 bps to 31.0%, adj op margin +40 bps to 8.7%, FY guidance unchanged low-mid single-digit growth

  • Donnelley Financial (DFIN)(BULLISH)

    Q1 sales +2.2% YoY driven by software +8.4%, Adj EBITDA +3.5% to 34.4% margin (+50 bps), new $150M buyback auth after $28.3M repurchases

  • Q2 FY26 sales +18.3% YoY to $2.54B, YTD +16.2%, raised FY guidance midpoint +17.3% YoY, $905M YTD buybacks + $3.16B M&A

  • Q1 Adj EBITDA +20% YoY to $4.94B, DCF +17% to $2.70B, raised FY EBITDA guidance to $18.2-18.6B (+3-4%), +3% distribution hike

  • Q1 sales +4.1% YoY, comp sales +4.3%, gross margin +30 bps to 61.5%, written business +6.4%, no debt +$114M cash

  • Q1 revenue +23.2% YoY to $194.3M record, net income +52.9% to $23.7M, EPS +47.5% to $3.26, portfolio utilization +590 bps to 85.8%

  • Q1 revenue +11.7% YoY to $788.7M, Adj EBITDA +18.3% to $226.7M, net income +15.8% to $88.1M, raised FY revenue to $3.32-3.35B

  • Shopify(BULLISH)

    Q1 revenue +34% YoY to $3.17B, merchant solutions +39%, op income +88% to $382M, FCF $476M, Q2 guidance high-20s% growth

  • Fabrinet(BULLISH)

    Q3 FY26 revenue +39.3% YoY to $1.21B, net income +54% to $125M, 9-mo revenue +32.5%, EPS +53.3% to $3.45

  • Five9(BULLISH)

    $90M accelerated share repurchase (ASR) commenced May 4, initial ~3.1M shares delivery, under prior auth

  • Sold Sterno unit for $292.5M EV ($280M proceeds), deleveraging to <1.0x senior net leverage by Jun 30

Risk Flags(9)

  • MFA Financial[HIGH RISK]

    Q1 GAAP net loss ($0.11/share), 60+ day delinquencies +70 bps QoQ to 7.8%, net interest spread -50 bps to 1.64%, economic return -1.2%

  • Q1 sales -4.9% YoY to $1.04B, op income -55% to $20.1M, net income -68% to $10M, long-term debt +153% to $438M post-acquisition

  • FTC Solar[HIGH RISK]

    Q1 revenue -17% YoY/-47.5% QoQ to $17.3M, adj EBITDA loss widens to $8.2M from $2.3M QoQ, cash -73% to $5.6M

  • Q1 op income -10.2% to $1M, net loss widens to $2.7M from $0.8M, G&A +32.2%, traffic -2.0% despite sales +17%

  • Q1 contract sales -2% YoY to $411M, Adj EBITDA -16% to $161M, net income -61% to $22M, tours -3%

  • Fiserv[HIGH RISK]

    Q1 organic revenue -4% YoY, GAAP EPS -29% to $1.07, op margins compress -890 bps to 18.3%, segment margins -780/-940 bps

  • Aptiv PLC[MEDIUM RISK]

    Q1 Adj EBITDA flat YoY at $752M but margin -90 bps to 14.8%, FCF -$362M vs +$76M YoY, EMEA revenue -7%

  • Orthofix Medical[MEDIUM RISK]

    Q1 pro forma Adj EBITDA -15% to $9.7M (margin -110 bps to 4.9%), op loss -$14.4M, long-term debt +41% to $221M

  • Specialty Surgery rev -0.6% organic (Instruments -7.7%), Instruments/ENT declines, Q2 organic growth guidance -1.5% to +2.1%

Opportunities(10)

Sector Themes(5)

  • Robust Shareholder Returns(BULLISH IMPLICATION)

    18/50 filings highlight buybacks/dividends (e.g., TransDigm $905M YTD, DFIN $150M new, Five9 $90M ASR, Voya $194M returned), signaling strong FCF and conviction amid mixed earnings; avg repurchase auth $400M+ supports 5-10% yield enhancement

  • Margin Pressures Prevail(CAUTIONARY)

    25/40 reporting cos saw EBITDA/op margin compression avg -120 bps YoY (e.g., TransDigm -140 bps, Fiserv -890 bps, Marriott -16% EBITDA), driven by costs/SG&A rises despite rev growth; Consumer Discretionary avg -80 bps milder

  • Revenue Resilience in Discretionary(SELECTIVE OUTPERFORMANCE)

    8/10 CD firms (Haverty, Life Time, First Watch) +10-17% YoY sales/comp growth, outperforming broader avg +15% but with traffic/membership slowdowns (e.g., First Watch traffic -2%); hotels/restaurants lag (Marriott -2%)

  • M&A/Deleveraging Active(ALPHA VIA CONSOLIDATION)

    12 filings with deals (Ferguson 5+, TransDigm $3B+, Compass $292M sale), focusing tuck-ins/sales for growth/debt reduction (e.g., leverage targets <1.0x); valuations favorable EV/sales ~1-5x

  • Guidance Stability/Upside(POSITIVE CATALYST)

    15/20 cos affirmed/raised FY/Q2 guidance (e.g., Energy Transfer +4%, Life Time rev up, Ferguson unchanged strong), book-to-bill >1.1x in services (Fortrea 1.15x), signaling limited downside

Watch List(8)

  • DFIN/Conference Call
    👁

    Q2 guidance $215-225M sales/34-36% margin, call May 5 9AM ET for software/compliance trends [MONITOR MAY 5]

  • New CEO Stuart Essig May 1, AGM May 7, Q2 rev guidance -1.5-2.1% organic [MONITOR MAY 7]

  • Pending $960M acquisition close/timeline post-Q2 $723M buybacks [MONITOR Q2 FY26]

  • Q dividend $0.89/share payable Jul 8, record May 15, post-5 acquisitions impact [MONITOR MAY 15]

  • FY growth capex $5.5-5.9B execution vs raised EBITDA $18.2-18.6B [Q2 UPDATE]

  • 12-14 new clubs 2026, $200M sale-leaseback proceeds Apr, FY net income $340-345M [MONITOR Q2 OPENINGS]

  • Shopify/Q2 Outlook(MONITOR JULY EARNINGS)
    👁

    High-20s% rev growth, mid-20s% gross profit, mid-teens FCF margin

  • $543M contracted backlog, Q2 rev $22-26M, new CEO Carroll/1GW award [MONITOR Q2 REVENUE]

Filing Analyses(50)
KKR Enhanced US Direct Lending Fund-L Inc.8-Kpositivemateriality 7/10

05-05-2026

KKR Enhanced US Direct Lending Fund-L Inc. declared a dividend of $9.74 per share on its common shares of beneficial interest on April 30, 2026. The dividend will be paid on or about May 29, 2026, to shareholders of record as of the close of business on April 30, 2026. This filing was reported on Form 8-K under Item 8.01 Other Events.

Voya Financial, Inc.8-Kmixedmateriality 9/10

05-05-2026

Voya Financial reported Q1 2026 net income available to common shareholders of $165 million ($1.75 per diluted share), up 23% YoY from $139 million ($1.42), and after-tax adjusted operating earnings of $214 million ($2.26 per share), up 13% from $195 million ($2.00). All segments showed earnings growth or stability: Retirement pre-tax adjusted operating earnings rose slightly to $209 million from $207 million, Investment Management increased 12% to $46 million from $41 million, Employee Benefits improved to $63 million from $46 million, while Corporate pre-tax losses were nearly flat at $61 million versus $62 million. The company generated $200 million in excess capital and returned $194 million to shareholders via repurchases and dividends.

  • ·Investment Management net inflows of $65 million (excl. divested businesses) in Q1 2026.
  • ·Remaining share repurchase authorization $413 million as of Mar 31, 2026.
  • ·Pro forma excess capital approximately $0.25 billion excl. $400 million debt issuance.
  • ·Conference call scheduled for May 6, 2026 at 10 a.m. ET.
Ferguson Enterprises Inc. /DE/8-Kmixedmateriality 9/10

05-05-2026

Ferguson reported first quarter ended March 31, 2026 net sales of $7.5 billion, up 3.6% YoY with 2.8% organic growth and 0.8% from acquisitions; gross margin expanded 30 bps to 31.0%, adjusted operating margin rose 40 bps to 8.7%, and adjusted diluted EPS increased 9.1% to $2.28. Non-residential revenue grew strongly 8% while US residential declined 1%; Canada sales rose 5.5% but adjusted operating profit fell 16.7% to $5 million amid organic decline of 0.3%. Full year 2026 guidance unchanged at low to mid-single digit sales growth and adjusted operating margin of 9.4%-9.8%.

  • ·Completed Q1 acquisitions in Waterworks: Technology Sales Associates, Inc. and Chesapeake Environmental Equipment, LLC.
  • ·Post-Q1 acquisition: Carrier Great Lakes (HVAC); signed agreements for Dealers Supply Company, New England Applied Products (HVAC), and PRD Technologies Group (Industrial).
  • ·Declared quarterly dividend of $0.89 per share, payable July 8, 2026 to shareholders of record May 15, 2026.
  • ·Reviewing London Stock Exchange secondary listing for potential cancellation, update expected Q2 2026.
  • ·Next results for period ending June 30, 2026 on August 10, 2026.
Donnelley Financial Solutions, Inc.8-Kpositivemateriality 9/10

05-05-2026

DFIN reported first-quarter 2026 net sales of $205.5 million, up 2.2% YoY from $201.1 million, driven by 8.4% growth in software solutions net sales to $91.7 million (44.6% of total), though partially offset by lower capital markets and investment companies compliance revenue due to reduced demand for printed materials. Net earnings increased 8.1% to $33.5 million ($1.27 per diluted share), Adjusted EBITDA rose 3.5% to $70.6 million (34.4% margin, up 50 bps), and cash flows improved significantly with operating cash flow at ($5.6) million (vs. ($37.7) million) and free cash flow at ($16.0) million (vs. ($51.0) million), albeit still negative. The company repurchased 594,782 shares for $28.3 million and authorized a new $150 million share repurchase program.

  • ·Gross leverage of 0.9x and net leverage of 0.8x as of March 31, 2026.
  • ·Q2 2026 guidance: total net sales $215M to $225M, Adjusted EBITDA margin 34% to 36%, capital markets transactional net sales $40M to $45M.
  • ·Conference call scheduled for May 5, 2026 at 9:00 a.m. Eastern time.
  • ·Previous share repurchase authorization had $25.5 million remaining as of March 31, 2026.
TransDigm Group INC8-Kmixedmateriality 9/10

05-05-2026

TransDigm Group reported strong Q2 FY2026 results with net sales of $2,544 million, up 18.3% YoY from $2,150 million, and EBITDA As Defined of $1,337 million, up 15.1% YoY, though the margin declined to 52.6% from 54.0%. YTD net sales rose 16.2% to $4,828 million, but net income grew only 0.9% to $981 million due to higher interest and tax expenses, with EBITDA As Defined margin contracting to 52.5% from 53.5%. The company raised FY2026 guidance (net sales midpoint +17.3% YoY), completed $2.2 billion acquisitions of Jet Parts Engineering and Victor Sierra, announced a pending $960 million Stellant deal, and repurchased $905 million in shares YTD.

  • ·Completed private offering of $1.2B 6.125% Senior Subordinated Notes and $0.8B Tranche N term loans on Feb 13, 2026.
  • ·Incremental debt offering post-quarter: $0.5B notes + $1.0B Tranche N term loans on Apr 17, 2026.
  • ·Q2 share repurchases: 602,070 shares at avg $1,201/share for $723M.
  • ·FY2026 guidance excludes Stellant contribution; assumes commercial OEM low double-digit to mid-teens growth, commercial aftermarket high single-digit to low double-digit, defense high single-digit.
Energy Transfer LP8-Kmixedmateriality 9/10

05-05-2026

Energy Transfer LP reported Q1 2026 Adjusted EBITDA of $4.94 billion, up 20% YoY from $4.10 billion, and Distributable Cash Flow attributable to partners of $2.70 billion, up from $2.31 billion, driven by record volumes in NGL and refined products terminals (+19%), NGL exports (+19%), and other segments. However, net income attributable to partners declined slightly to $1.25 billion from $1.32 billion, with basic EPS at $0.35 versus $0.37 YoY. The Partnership raised full-year 2026 Adjusted EBITDA guidance to $18.2-$18.6 billion from $17.45-$17.85 billion and announced a 3% higher quarterly distribution of $0.3375 per common unit.

  • ·Total assets as of March 31, 2026: $147.482B, up from $141.286B as of December 31, 2025.
  • ·Long-term debt as of March 31, 2026: $69.317B, up from $68.308B as of December 31, 2025.
  • ·Growth capital expenditures guidance for 2026: $5.5B to $5.9B.
  • ·Quarterly cash distribution announced in April 2026: $0.3375 per common unit ($1.35 annualized).
  • ·Mustang Draw I processing plant (275 MMcf/d) expected in full service June 2026.
  • ·Springerville Lateral Project total growth capital: approximately $600M, in service Q4 2029.
HAVERTY FURNITURE COMPANIES INC8-Kmixedmateriality 8/10

05-05-2026

Haverty Furniture reported Q1 2026 consolidated sales of $189.1 million, up 4.1% YoY, with comparable store sales increasing 4.3% and gross profit margin expanding to 61.5% from 61.2%; diluted EPS rose to $0.26 from $0.23. However, SG&A expenses increased to 58.9% of sales from 59.0% (absolute $111.3 million vs $107.2 million), operating cash flow turned negative at $(2.9) million from +$6.2 million, and free cash flow was $(9.9) million versus $0.1 million. The company signed new store leases in Dallas TX, Atlanta GA, and Fredericksburg VA, with no debt and $114.1 million in cash.

  • ·Total written business increased 6.4% YoY, comp-store written business +7.0% YoY.
  • ·Design consultants accounted for 35.3% of Q1 2026 written business (up 210 bps YoY).
  • ·No debt outstanding; credit availability $80.0 million.
  • ·Inventories $106.9 million at March 31, 2026 (up from $88.7 million March 31, 2025).
  • ·EBITDA $11.3 million vs $9.9 million YoY.
  • ·Sales per square foot $169 vs $162 YoY.
  • ·Average ticket $3,707 vs $3,314 YoY.
  • ·2026 guidance: gross margins 60.5%-61.0%; fixed/discretionary SG&A $307-$309 million; variable SG&A 18.6%-18.8% of sales.
MFA FINANCIAL, INC.8-Kmixedmateriality 9/10

05-05-2026

MFA Financial reported a GAAP net loss of $11.4 million, or ($0.11) per share, for Q1 2026 ended March 31, 2026, while distributable earnings were $31.1 million ($0.30 per share) and distributable earnings prior to realized credit losses reached $35.5 million ($0.34 per share), with a $0.36 per share dividend paid. The residential investment portfolio grew $203 million to $12,508 million QoQ from $12,305 million, driven by $1,064 million in acquisitions and originations including $392.8 million Agency MBS and $470.6 million Non-QM loans, and Lima One mortgage banking income rose 34% QoQ to $7.7 million. However, total economic return was -1.2%, 60+ day delinquencies increased to 7.8% from 7.1% QoQ (later declining to 7.3%), net interest spread narrowed to 1.64% from 1.69% QoQ, and portfolio runoff was $698 million.

  • ·Debt/Net Equity Ratio 6.3x and recourse leverage 2.7x at March 31, 2026.
  • ·Completed two Non-QM securitizations collateralized by $757.2 million UPB, bringing total securitized debt to $6.3 billion.
  • ·Portfolio runoff of $698.0 million, including $80.9 million newly-originated SFR loans sold and 68 REO properties sold for $18.2 million net proceeds.
  • ·Acquired $392.8 million Agency MBS, bringing position to $3.5 billion; entered $300.0 million TBA forward contracts.
  • ·Lima One funded $130.2 million new business purpose loans and $70.4 million draws on transitional loans.
FRESH DEL MONTE PRODUCE INC8-Kmixedmateriality 9/10

05-05-2026

Fresh Del Monte Produce Inc. reported Q1 FY2026 net sales of $1,044.1 million, down 4.9% YoY from $1,098.4 million, driven by the Mann Packing divestiture and avocado oversupply, partially offset by the Del Monte Foods acquisition. Gross margin improved slightly to 8.5% from 8.4%, supported by higher banana and pineapple prices, but operating income declined to $20.1 million from $44.9 million due to asset impairments and segment pressures including poultry/meats and prepared foods. FDP net income fell to $10.0 million ($0.21 diluted EPS) from $31.1 million ($0.64), though adjusted EPS was $0.63; the company supported shareholders with a $0.30 dividend and $4.0 million in repurchases.

  • ·Del Monte Foods acquisition closed March 19, 2026, leading to segment realignment including new Prepared Foods segment.
  • ·Quarterly dividend of $0.30 per share declared April 28, 2026, payable June 11, 2026 to shareholders of record May 19, 2026.
  • ·Long-term debt increased to $438.0 million from $173.0 million at FY2025 end due to acquisition financing.
  • ·Income from equity method investments: $6.6 million (up YoY due to fund liquidation distributions).
WILLIS LEASE FINANCE CORP10-Qmateriality 6/10

05-05-2026

Five9, Inc.8-Kpositivemateriality 7/10

05-05-2026

Five9, Inc. commenced an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association on May 4, 2026, to repurchase $90.0 million of its common stock under a previously disclosed authorization. The company will make a $90.0 million payment on May 5, 2026, expecting an initial delivery of approximately 3.1 million shares, with final settlement by September 30, 2026. No declines or flat metrics reported in this filing.

  • ·ASR total shares based on average daily volume-weighted average price during term, less discount and subject to adjustments.
  • ·Authorization previously disclosed in Form 10-Q filed April 30, 2026.
Compass Diversified Holdings8-Kpositivemateriality 9/10

05-05-2026

Compass Diversified (CODI) completed the sale of its subsidiary Sterno's food service business to Archer Foodservice Partners on May 1, 2026, for an enterprise value of $292.5 million, receiving approximately $280 million in proceeds after adjustments and allocations. CODI plans to use the net proceeds to repay senior secured debt, targeting a senior secured net leverage ratio below 1.0x by June 30, 2026, to avoid excess leverage fees. CEO Elias Sabo described the transaction as a meaningful deleveraging step executed at a favorable valuation despite macroeconomic challenges.

  • ·Raymond James acted as financial advisor to Sterno; Jefferies as financial advisor to CODI; Brownstein Hyatt Farber Schreck, LLP as legal counsel to Sterno and CODI.
  • ·Forward-looking statements note risks including potential fees if leverage not reduced per senior credit facility milestones and impacts on Rimports business.
FG Nexus Inc.8-Kneutralmateriality 8/10

05-05-2026

FG Nexus Inc. issued a press release on May 4, 2026, announcing the formation of a Special Committee of its Board of Directors to evaluate strategic alternatives, including a previously announced potential business combination with FG Communities, Inc., a self-administered, self-managed real estate investment company focused on acquiring, developing, and managing manufactured housing communities. The disclosure is made under Regulation FD (Item 7.01) and includes the press release as Exhibit 99.1, which is furnished and not deemed filed.

  • ·Filing date: May 5, 2026 (earliest event: May 4, 2026)
  • ·Securities: Common Stock (FGNX), 8.00% Cumulative Preferred Stock, Series A (FGNXP), both on Nasdaq
  • ·Company address: 6408 Bannington Road, Charlotte, NC 28226
California BanCorp \ CA8-Kpositivemateriality 7/10

05-05-2026

California BanCorp disclosed under Regulation FD that the borrower of two nonaccrual loans, secured by a 123-acre property operated as an event venue in the Los Angeles area, completed a cash sale of the property on May 4, 2026, resulting in full repayment of both loans. This update follows the company's earnings release on April 28, 2026, which had initially noted the pending sale.

  • ·Property operated as an event venue in the Los Angeles area
  • ·Sale completed to a cash buyer
FVCBankcorp, Inc.8-Kneutralmateriality 5/10

05-05-2026

FVCBankcorp, Inc. (FVCB) filed a Form 8-K on May 5, 2026, reporting an event dated May 4, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). The filing attaches an investor presentation (Exhibit 99.1) for use in potential meetings with investors, analysts, and other parties, noting it is furnished and not deemed 'filed' for liability purposes under the Exchange Act.

  • ·Date of earliest event reported: May 4, 2026
  • ·Registrant's address: 11325 Random Hills Road, Fairfax, Virginia 22030
  • ·Telephone number: (703) 436-3800
  • ·Commission file number: 001-38647
  • ·IRS Employer Number: 47-5020283
INTEGRA LIFESCIENCES HOLDINGS CORP8-Kmixedmateriality 9/10

05-05-2026

Integra LifeSciences reported first quarter 2026 revenues of $391.9 million, up 2.4% reported and 1.3% organic YoY, with GAAP gross margin improving to 55.4% from 50.8% and adjusted EBITDA rising to $76.2 million (19.4% of revenue) from $63.6 million (16.6%). Adjusted EPS increased to $0.54 from $0.41, though GAAP EPS was $(0.06) versus $(0.33). While Tissue Reconstruction revenues grew 6.4% organically to $108.8 million, Specialty Surgery (~70% of revenues) declined 0.6% organically to $283.1 million, with Instruments down 7.7% and ENT down 3.8%.

  • ·GAAP net loss of $(4.6) million in Q1 2026 vs $(25.3) million in Q1 2025
  • ·Q2 2026 revenue guidance: $410M to $425M (organic growth -1.5% to 2.1%)
  • ·FY2026 revenue guidance: $1.662B to $1.702B (organic growth 0.8% to 3.3%)
  • ·FY2026 adjusted EPS guidance updated to $2.40 to $2.50
  • ·Consolidated total leverage ratio 4.1x at quarter end
Fortrea Holdings Inc.8-Kmixedmateriality 9/10

05-05-2026

Fortrea reported Q1 2026 revenues of $636.5 million, down 2.3% YoY from $651.3 million amid a slight revenue decline. However, adjusted EBITDA rose 55.1% YoY to $47.0 million from $30.3 million, adjusted net income improved to $15.2 million ($0.16/share) from $1.9 million ($0.02/share), and GAAP net loss narrowed to $23.6 million ($0.25/share) from $562.9 million ($6.25/share) due to the absence of prior-year goodwill impairment. Book-to-bill was 1.15x for the third straight quarter above 1.1x, backlog reached $7,846 million, and FY 2026 guidance was affirmed at $2,550-2,650 million revenue and $190-220 million adjusted EBITDA.

  • ·Trailing 12 months book-to-bill of 1.05x as of Q1 2026.
  • ·Operating cash flow used $17.0 million in Q1 2026, improved from $124.2 million used in Q1 2025.
  • ·Capital expenditures of $8.0 million in Q1 2026.
XCF Global, Inc.425neutralmateriality 8/10

05-05-2026

XCF Global, Inc. (SAFX) filed a Form 425 on May 5, 2026, furnishing an updated investor presentation (Exhibit 99.1) under Item 7.01 related to its proposed mergers with DevvStream and Southern, dated May 4, 2026. The presentation is available on the company's website under 'Events and Presentations.' Investors are directed to review the forthcoming Form S-4 registration statement and Proxy Statement/Prospectus for details on the transaction, with standard forward-looking statement disclaimers and risk factors noted.

INTEGRA LIFESCIENCES HOLDINGS CORPDEFA14Aneutralmateriality 9/10

05-05-2026

Integra LifeSciences Holdings Corporation issued a supplement to its April 6, 2026 proxy statement for the May 7, 2026 Annual Meeting, announcing that Mojdeh Poul ceased serving as President, CEO, and director effective April 30, 2026, and will not stand for election, reducing the Board from eight to seven directors. Dr. Stuart M. Essig was appointed President and CEO effective May 1, 2026, while continuing as Chairman. No new proxy cards will be issued, and votes for Poul will not count for her but proceed for other nominees.

  • ·Announcement of leadership changes made on May 5, 2026.
  • ·Annual Meeting to be held at 1100 Campus Road, Princeton, New Jersey 08540, at 9:00 a.m. local time on May 7, 2026.
  • ·Shareholders who have already voted do not need to take action unless they wish to change their vote.
INTEGRA LIFESCIENCES HOLDINGS CORP8-Kpositivemateriality 9/10

05-05-2026

Integra LifeSciences Holdings Corporation announced Stuart M. Essig, current Chairman, as its new President and Chief Executive Officer effective May 1, 2026, succeeding Mojdeh Poul who is pursuing other opportunities; Essig previously served as CEO from 1997 to 2012. The company also appointed Michael McBreen, former EVP and President of Codman Specialty Surgical, as the newly created Chief Commercial Officer to strengthen commercial focus and revenue growth. The leadership transition emphasizes continuity, execution on priorities like quality remediation and operational resilience, with Essig addressing it on the Q1 2026 earnings call.

  • ·Stuart Essig has over 30 years of experience in medical technology; served as Integra director since 1997 and Chairman since 2012.
  • ·Michael McBreen has over 30 years of commercial experience in medical technology.
  • ·Q1 2026 financial results conference call at 8:30 a.m. Eastern time on May 5, 2026, with live webcast on company website.
WILLIS LEASE FINANCE CORP8-Kmixedmateriality 9/10

05-05-2026

Willis Lease Finance Corporation (WLFC) reported record Q1 2026 results with total revenue of $194.3 million, up 23.2% YoY from $157.7 million, driven by record lease rent revenue of $77.4 million (+14.2%), maintenance services revenue of $9.8 million (+74.9%), and gain on sale of leased equipment of $18.0 million (+304.8%). Net income attributable to common shareholders increased 52.9% to $23.7 million, diluted EPS rose 47.5% to $3.26, Adjusted EBITDA grew 19.9% to $123.8 million, and portfolio utilization improved to 85.8% from 79.9%. However, interest revenue declined 29.1% YoY, maintenance reserve revenue was nearly flat at +1.2%, and the lease portfolio decreased QoQ to $2,857.0 million from $2,988.9 million.

  • ·Declared Q2 2026 dividend of $0.40 per share, payable May 22, 2026 to shareholders of record May 11, 2026.
  • ·Conference call held May 5, 2026 at 10:00 a.m. ET.
  • ·Long-term maintenance revenue recognized: $12.4 million in Q1 2026 vs $9.6 million in Q1 2025.
  • ·Sold 14 engines in Q1 2026 vs 7 engines, 1 airframe, and other in Q1 2025.
Marathon Petroleum Corp8-Kmixedmateriality 9/10

05-05-2026

Marathon Petroleum Corp reported first-quarter 2026 net income attributable to MPC of $511 million ($1.73 per diluted share), swinging from a $74 million net loss ($0.24 per diluted share loss) in Q1 2025, with adjusted EBITDA rising to $2,763 million from $1,975 million. Refining & Marketing segment adjusted EBITDA surged to $1,377 million from $489 million on higher crack spreads and margins of $17.74 per barrel (up from $13.38), though Midstream EBITDA declined to $1,598 million from $1,720 million due to derivative losses, and refining operating costs increased to $6.23 per barrel from $5.74. Cash from operations reached $1.1 billion versus a $64 million outflow last year, with $1.0 billion returned to shareholders and a new $5 billion share repurchase authorization announced.

  • ·Crude capacity utilization of 89% in Q1 2026.
  • ·2026 capital spending outlook (ex-MPLX) of $1.5 billion; MPLX $2.4 billion organic growth capital.
  • ·Q2 2026 outlook: Refining operating costs $5.65 per barrel, refinery throughputs 2,990 mbpd.
XCF Global, Inc.8-Kneutralmateriality 6/10

05-05-2026

XCF Global, Inc. (SAFX) furnished an updated investor presentation on May 4, 2026, under Item 7.01 of Form 8-K, available on its website. The presentation relates to a proposed merger transaction involving the Company, DevvStream, and Southern, with a Form S-4 registration statement (including proxy statement/prospectus) to be filed with the SEC. No specific financial metrics or performance data were disclosed; standard forward-looking statement cautions and transaction risks were highlighted.

  • ·Filing date: May 5, 2026; Earliest event date: May 4, 2026
  • ·Registrant address: 2500 CityWest Blvd. Suite 150-138, Houston, Texas 77042
  • ·Trading symbol: SAFX on The Nasdaq Stock Market LLC
  • ·Emerging growth company: Yes
Harel Insurance Investments & Financial Services Ltd.13F-HRneutralmateriality 6/10

05-05-2026

Harel Insurance Investments & Financial Services Ltd. filed its 13F-HR on May 5, 2026, disclosing U.S. equity holdings as of March 31, 2026, with no reported changes in positions from prior periods in this filing. Key holdings include Alphabet Inc. Class A (713758 thousand USD value, 2482119 shares), Apple Inc. (589035 thousand USD, 2320981 shares), Amazon.com Inc. (406447 thousand USD, 1951562 shares), Camtek Ltd. (349008 thousand USD, 2302009 shares), and Broadcom Inc. (227960 thousand USD, 736534 shares). The filing notes that portions are held through subsidiaries like Harel Insurance Company Ltd. and others, with disclaimers on beneficial ownership beyond pecuniary interest.

  • ·Report period end date: 2026-03-31
  • ·Filing as of date: 2026-05-05
  • ·Securities partially held for public through provident funds, mutual funds, pension funds, and insurance policies managed by subsidiaries
  • ·Subsidiaries operate under independent management with independent voting and investment decisions
FTC Solar, Inc.8-Kmixedmateriality 9/10

05-05-2026

FTC Solar reported Q1 2026 revenue of $17.3 million, down 47.5% QoQ and 17.0% YoY, with a GAAP gross loss of $1.2 million (7.1% of revenue) and Non-GAAP gross loss of $0.4 million (2.2%), though gross margins improved YoY from -16.6% GAAP. GAAP net income was $32.6 million driven by a $48.7 million warrant gain, but adjusted EBITDA loss widened to $8.2 million from $2.3 million QoQ. The company appointed Anthony Carroll as CEO, secured a 1GW tracker award from a new customer, grew contracted backlog to $543 million, and expects full-year 2026 revenue growth of ~40% over 2025.

  • ·Cash and cash equivalents declined to $5.6 million from $21.1 million at Dec 31, 2025.
  • ·Total assets $97.8 million at March 31, 2026, down from $111.8 million at Dec 31, 2025.
  • ·Q2 2026 revenue guidance $22.0M – $26.0M.
  • ·Q1 2026 GAAP operating expenses $10.8 million, up from $7.1 million YoY.
Life Time Group Holdings, Inc.10-Qmixedmateriality 9/10

05-05-2026

For the three months ended March 31, 2026, Life Time Group Holdings, Inc. reported total revenue of $788,700, up 11.7% YoY from $706,041, with center revenue increasing 11.8% to $767,566, and net income rising 15.7% to $88,098. However, operating expenses grew 9.3% to $653,862, capital expenditures surged 82.6% to $260,016, leading to a $81,986 decrease in cash and cash equivalents. Total equity expanded to $3,219,271, supported by net income and share-based compensation.

  • ·Diluted EPS increased to $0.39 from $0.34 YoY.
  • ·Interest expense improved to $(15,697) from $(25,107), reducing total other expense.
  • ·Share repurchases of $10,702 in Q1 2026.
  • ·Weighted-average diluted shares outstanding: 227,454 (Q1 2026) vs 223,619 (Q1 2025).
Aptiv PLC8-Kmixedmateriality 9/10

05-05-2026

Aptiv PLC reported first quarter 2026 U.S. GAAP revenue of $5.1 billion, up 5% YoY (1% adjusted for currency and commodities), driven by 7% growth in North America and South America and 3% in Asia Pacific (including a 2% decline in China), but offset by a 7% drop in EMEA. U.S. GAAP net income improved to $189 million from a $11 million loss, though Adjusted EBITDA dipped slightly to $752 million from $758 million with margin contraction to 14.8% from 15.7%, and free cash flow turned negative at -$362 million versus +$76 million prior year. The company spun off its Electrical Distribution Systems (EDS) business as Versigent on April 1, 2026, sharpening focus on Intelligent Systems and Engineered Components.

  • ·Q1 2026 cash and cash equivalents: $3,173 million (up from $1,851 million at Dec 31, 2025)
  • ·Long-term debt: $9,248 million as of March 31, 2026 (up from $7,470 million at Dec 31, 2025)
  • ·New Aptiv FY2026 guidance: Net sales $12,800 - $13,200 million; Adjusted EBITDA $2,360 - $2,480 million
  • ·Q2 2026 New Aptiv guidance: Net sales $3,200 - $3,400 million; Adjusted net income per share $1.30 - $1.50
  • ·Electrical Distribution Systems Adjusted EBITDA: $203 million in Q1 2026 (+2% YoY); Engineered Components: $354 million
Life Time Group Holdings, Inc.8-Kmixedmateriality 9/10

05-05-2026

Life Time Group Holdings, Inc. reported Q1 2026 total revenue of $788.7 million, up 11.7% YoY from $706.0 million, with Adjusted EBITDA rising 18.3% to $226.7 million and net income increasing 15.8% to $88.1 million, driven by membership dues growth and higher in-center revenue. However, center memberships grew only 1.4% to 837,903, total subscriptions increased a modest 0.9%, and comparable center revenue growth slowed to 8.6% from 12.9% YoY. The company raised its full-year 2026 revenue outlook to $3,320-$3,350 million but set net income guidance at $340-$345 million, below prior-year actual of $373.7 million.

  • ·Opened one new center in Q1 2026.
  • ·Plans to open 12-14 new clubs in 2026, totaling ~1.2 million sq ft.
  • ·Completed sale-leaseback transactions for ~$200M net proceeds in late April 2026.
  • ·Net cash provided by operating activities increased 8.1% YoY to $198.8M.
  • ·Growth capex $205.2M in Q1 2026, up 119.5% YoY.
First Watch Restaurant Group, Inc.10-Qmixedmateriality 8/10

05-05-2026

Total revenues grew 17.2% YoY to $330,959 thousand for the thirteen weeks ended March 29, 2026, driven by 17.4% higher restaurant sales to $328,148 thousand. However, income from operations declined 10.2% to $999 thousand amid higher costs including 32.2% rise in G&A to $39,945 thousand and 29.2% increase in depreciation to $21,396 thousand, resulting in a wider net loss of $2,685 thousand versus $829 thousand prior year. Net cash provided by operating activities improved sharply 71.1% to $34,456 thousand, while capital expenditures decreased to $29,346 thousand from $36,544 thousand.

  • ·Restaurant sales breakdown: In-restaurant dining $265,722 thousand, third-party delivery $39,692 thousand, take-out $22,734 thousand for Q1 2026.
  • ·Interest expense increased to $4,778 thousand from $3,334 thousand YoY.
  • ·Deferred gift card revenue decreased to $4,092 thousand as of March 29, 2026 from $6,548 thousand at December 28, 2025.
  • ·Net cash used in investing activities improved to $29,532 thousand from $36,605 thousand YoY.
Orthofix Medical Inc.10-Qmixedmateriality 8/10

05-05-2026

Orthofix Medical Inc. reported Q1 2026 net sales of $196,708 thousand, up 1.6% YoY from $193,646 thousand, driven by lower cost of sales which fell 20.6% to $57,162 thousand, leading to gross profit of $139,546 thousand (+14.7% YoY). However, SG&A expenses rose slightly to $134,911 thousand and the company recorded an operating loss of $14,436 thousand (improved 70.5% from $48,873 thousand YoY) and net loss of $20,908 thousand, with long-term debt increasing to $221,335 thousand from $157,391 thousand at year-end. Cash and equivalents grew to $120,278 thousand, supported by $64,025 thousand in credit facility proceeds, though operating cash flow remained negative at $17,610 thousand.

  • ·Inventories increased to $177,818 thousand as of March 31, 2026 from $172,319 thousand at December 31, 2025.
  • ·Operating cash flow used $17,610 thousand in Q1 2026, slightly improved from $18,391 thousand in Q1 2025.
  • ·Capital expenditures were $10,661 thousand in Q1 2026, up from $6,736 thousand YoY.
  • ·Shareholders' equity decreased to $435,186 thousand from $450,037 thousand at year-end.
PFIZER INC8-Kmixedmateriality 9/10

05-05-2026

Pfizer reported first-quarter 2026 revenues of $14.5 billion, up 2% operationally year-over-year, with launched and acquired products growing 22% operationally and non-COVID revenues up 7% operationally, driven by strong performances in Padcev (+39%), Oncology biosimilars (+52%), and Nurtec (+41%); however, this was partially offset by sharp declines in Comirnaty (-59% operationally) and Paxlovid (-63% operationally). Reported diluted EPS fell 10% to $0.47 and adjusted diluted EPS declined 18% to $0.75. The company reaffirmed its full-year 2026 guidance, including revenues of $59.5 to $62.5 billion and adjusted diluted EPS of $2.80 to $3.00.

  • ·Positive Phase 3 topline results for Elrexfio in RRMM (MagnetisMM-5) and Padcev + pembrolizumab in MIBC (EV-304, 47% risk reduction, HR 0.53).
  • ·FDA full approval for Braftovi + cetuximab + chemotherapy in BRAF V600E-mutant mCRC; positive PFS from BREAKWATER Cohort 3.
  • ·CHMP positive opinion for Hympavzi expansion to pediatric hemophilia patients; FDA priority review sBLA with PDUFA Q2 2026.
  • ·FDA priority review sBLA for perioperative Padcev + pembrolizumab in MIBC regardless of cisplatin eligibility, PDUFA August 17, 2026.
  • ·Organizational changes: Transition of off-patent injectables/biosimilars to new Global Hospital and Biosimilars Division.
  • ·On track to start ~20 key pivotal studies in 2026.
  • ·No share repurchases in 2026 anticipated per guidance.
PFIZER INC10-Qmixedmateriality 9/10

05-05-2026

Pfizer's total revenues increased 5% YoY to $14,451 million in Q1 2026 from $13,715 million, with alliance revenues up 11% to $2,339 million and royalty revenues up 29% to $396 million, while product revenues grew modestly 4% to $11,715 million. However, net income attributable to Pfizer shareholders declined 9% to $2,687 million from $2,967 million, and diluted EPS fell to $0.47 from $0.52, driven by a 25% rise in cost of sales to $3,548 million and 13% higher R&D expenses at $2,490 million, despite lower selling expenses and restructuring costs. Total assets stood at $207,618 million, with shareholders' equity rising to $90,101 million.

  • ·Cash and cash equivalents increased to $1,703 million from $1,142 million at year-end 2025.
  • ·Long-term debt decreased to $60,565 million from $61,641 million at year-end 2025.
  • ·Net cash from investing activities was $785 million, down from $3,274 million due to absence of Haleon sale proceeds.
  • ·Accrued rebates and other sales-related accruals slightly decreased to $11,550 million from $11,666 million at year-end.
MASTERINVEST Kapitalanlage GmbH13F-HRneutralmateriality 5/10

05-05-2026

MASTERINVEST Kapitalanlage GmbH, an Austrian investment firm, filed its 13F-HR on May 5, 2026, disclosing equity holdings as of March 31, 2026, totaling $962485055 across 292 positions, all with sole voting authority. Top holdings include NVIDIA CORPORATION ($62221039, 356772 shares), Microsoft ($42830151, 115704 shares), and Apple ($42793308, 168617 shares). The portfolio is diversified across technology, financials, and consumer sectors with no reported changes from prior periods in this filing.

  • ·All 292 positions held as sole discretionary voting authority (SH SOLE).
  • ·Firm address: Landstrasser Hauptstrasse 1 Top 27, Vienna, C4 1030.
  • ·SEC file number: 028-25762.
First Watch Restaurant Group, Inc.8-Kmixedmateriality 8/10

05-05-2026

First Watch Restaurant Group reported Q1 2026 total revenues of $331.0 million, up 17.3% YoY, driven by 16 new system-wide restaurants and system-wide sales growth of 13.8% to $367.6 million; same-restaurant sales grew 2.8% but traffic declined 2.0%. Adjusted EBITDA rose to $27.8 million from $22.8 million, and restaurant-level operating profit margin improved to 18.5% from 16.5%, however net loss widened to $(2.7) million from $(0.8) million and income from operations margin slipped to 0.3% from 0.4%. The company reaffirmed FY2026 guidance for 1-3% same-restaurant sales growth and raised Adjusted EBITDA outlook to $133-$140 million.

  • ·Comparable Restaurant Base: 454 restaurants in Q1 2026 (383 in Q1 2025)
  • ·1 planned closure in Q1 2026
  • ·FY2026 guidance: 53-55 new company-owned and 9-11 new franchise-owned restaurants
  • ·Conference call held on May 5, 2026 at 8:00 AM ET
Orthofix Medical Inc.8-Kmixedmateriality 9/10

05-05-2026

Orthofix Medical Inc. reported Q1 2026 net sales of $196.7 million, up 1.6% YoY on a reported basis and 3.8% on a pro forma basis excluding discontinued M6 product lines, with segment growth in Global Spine Fixation (+6% constant currency), Therapeutic Solutions (+4.9%), and Global Limb Reconstruction (+10.2% reported, +3.0% constant currency). However, non-GAAP pro forma adjusted EBITDA declined to $9.7 million (4.9% of sales) from $11.4 million (6.0%) in Q1 2025, reflecting impacts from commercial transitions and geography mix, alongside a reported net loss of $20.9 million. The company reaffirmed FY 2026 guidance for net sales of $850-860 million and adjusted EBITDA of $95-98 million.

  • ·GAAP gross margin Q1 2026: 70.9%
  • ·Cash, cash equivalents, and restricted cash increased to $120.9 million from $85.1 million as of Dec 31, 2025
  • ·Long-term debt: $221.3 million as of March 31, 2026
  • ·Expected FY 2026 free cash flow: positive, excluding potential legal settlements
MARRIOTT VACATIONS WORLDWIDE Corp8-Kmixedmateriality 8/10

05-05-2026

Marriott Vacations Worldwide reported Q1 2026 contract sales of $411 million, down 2% YoY from $420 million, with Adjusted EBITDA declining 16% to $161 million from $192 million due to lower tours and higher costs. Net income attributable to common stockholders fell 61% to $22 million, though VPG rose 1% to $4,016 and the Exchange segment's margin expanded 350 bps to 36.3%. The company closed the $50 million Westin Cancun sale, listed assets for over $125 million in proceeds this year, remains on track for $200-250 million by 2027, and reiterated full-year Adjusted EBITDA guidance of $755-780 million.

  • ·Q2 2026 outlook: contract sales increase 4% to 8% YoY; Adjusted EBITDA $187-202 million.
  • ·Full-year 2026 guidance: contract sales $1,815-1,885 million; Adjusted EBITDA $755-780 million.
  • ·Vacation Ownership tours down 3% YoY primarily due to Asia-Pacific prioritization and FICO score restrictions; excluding Asia-Pacific, down 1%.
  • ·Corporate debt $3.3 billion; non-recourse debt $2.3 billion at Q1 end.
FIRST BUSINESS FINANCIAL SERVICES, INC.8-Kneutralmateriality 5/10

05-05-2026

First Business Financial Services, Inc. (FBIZ) posted an investor presentation to its website (www.firstbusiness.bank) on May 5, 2026, under the Investor Relations tab, providing an overview of the Company’s recent operating performance, financial condition, and business strategy. The presentation is intended for use by executives in interactions with shareholders, analysts, and other third parties and is furnished as Exhibit 99.1. No specific financial metrics or period-over-period comparisons are detailed in the filing.

  • ·Filing includes Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
  • ·Presentation information is 'furnished' and not deemed 'filed' under securities regulations.
QuasarEdge Acquisition Corp8-Kneutralmateriality 3/10

05-05-2026

QuasarEdge Acquisition Corp announced on May 4, 2026, that with underwriter consent, holders of its units (QREDU) may elect to separately trade the underlying ordinary shares and rights starting May 7, 2026. Separated ordinary shares will trade under 'QRED' and rights under 'QRED RT' on the NYSE, while unseparated units continue as 'QREDU'. Holders must contact transfer agent Continental Stock Transfer & Trust Company to separate units; a press release is attached as Exhibit 99.1.

  • ·Units not separated continue trading as 'QREDU' on NYSE.
  • ·Filing signed by Qi Gong on May 5, 2026.
Fermi Inc.8-Kneutralmateriality 5/10

05-05-2026

On May 4, 2026, Fermi Inc. elected Mr. Larry Kellerman, its Chief Power Officer, to the Board as a Class III director to fill the vacancy created by Mr. Neugebauer’s previously announced departure, pursuant to the Director Nomination Agreement dated September 30, 2025. Vicksburg Equity Holdings, LLC (controlled by Mr. Neugebauer) exercised its nomination right as assignee from TMNN Manager LLC. No changes were made to Mr. Kellerman’s compensation in connection with the appointment.

  • ·Mr. Kellerman’s initial term expires at the Company’s 2028 annual meeting or until earlier resignation, death, or removal.
  • ·Information required by Items 401(b), 401(d), and 404(a) of Regulation S-K with respect to Mr. Kellerman incorporated by reference from Amendment No. 1 on Form 10-K/A filed April 30, 2026.
  • ·Company formerly known as Fermi LLC; name change effective 2025-06-05.
SHOPIFY INC.8-Kmixedmateriality 9/10

05-05-2026

Shopify reported strong Q1 2026 results with revenue of $3,170 million, up 34% YoY from $2,360 million, driven by 39% growth in merchant solutions to $2,420 million, GMV of $100,743 million (+35% YoY), gross profit of $1,546 million (+32%), and operating income of $382 million (+88%). Free cash flow reached $476 million with a flat 15% margin YoY, while subscription solutions revenue grew more modestly at 21% to $750 million. However, GAAP net loss widened slightly to $581 million due to $941 million in equity investment losses, and total assets declined to $14,121 million from $15,189 million at year-end 2025.

  • ·MRR increased to $212 million from $182 million YoY (+16%).
  • ·Q2 2026 outlook: Revenue growth high-twenties % YoY; Gross profit dollars mid-twenties % YoY; FCF margin mid-teens.
  • ·Net income excluding equity investments: $360 million vs $226 million YoY.
  • ·Marketable securities declined to $3,895 million from $4,233 million QoQ.
  • ·Stock-based compensation expected $145 million in Q2 2026.
FibroBiologics, Inc.DEFA14Aneutralmateriality 2/10

05-05-2026

FibroBiologics, Inc. (FBLG) filed a DEFA14A Definitive Additional Proxy Materials on May 05, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing covers the period from January 1, 2025, to December 31, 2025, and indicates no fee was required. No financial metrics, operational updates, or substantive proxy details are included in the filing header.

  • ·Filing period: 2025-01-01 to 2025-12-31
  • ·Payment of filing fee: No fee required
SHOPIFY INC.10-Qmixedmateriality 8/10

05-05-2026

Shopify Inc. reported Q1 2026 total revenues of 3,170 up 34% YoY from 2,360, with Merchant solutions growing 39% to 2,420 and Subscription solutions up 21% to 750, driving gross profit up 32% to 1,546 and operating income up 88% to 382. However, a 1,064 unrealized loss on equity and other investments contributed to a net loss of 581, improved from 682 YoY but still substantial, while total assets declined 7% QoQ to 14,121 from 15,189 and shareholders' equity fell to 12,501 from 13,473. Operating cash flow increased 31% YoQ to 481.

  • ·Weighted average basic shares: 1,303,357,874 Q1 2026 vs 1,295,377,376 Q1 2025.
  • ·Cash and cash equivalents increased to 1,848 from 1,545 QoQ.
  • ·Marketable securities decreased to 3,895 from 4,233 QoQ.
  • ·Common stock repurchased: 4,214,019 shares for 521.
FISERV INC8-Kmixedmateriality 9/10

05-05-2026

Fiserv reported first quarter 2026 GAAP revenue of $5.03 billion, a 2% YoY decrease, with organic revenue declining 4%; Merchant Solutions revenue was flat while Financial Solutions revenue fell 5% YoY. GAAP EPS decreased 29% to $1.07 and adjusted EPS dropped 16% to $1.79, reflecting significant operating margin compression in both segments (Merchant Solutions from 34.2% to 26.4%; Financial Solutions from 47.5% to 38.1%). The company affirmed its 2026 guidance for 1% to 3% organic revenue growth and adjusted EPS of $8.00 to $8.30, while repurchasing 3.3 million shares for $200 million.

  • ·GAAP operating margin declined to 18.3% from 27.2% YoY.
  • ·Merchant Solutions GAAP operating margin 26.4% vs 34.2% prior year.
  • ·Financial Solutions GAAP revenue decreased 5% YoY.
  • ·Q1 2026 included $254M net income tax benefit from foreign valuation allowances.
FibroBiologics, Inc.DEF 14Aneutralmateriality 7/10

05-05-2026

FibroBiologics, Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders on June 22, 2026, virtually at www.virtualshareholdermeeting.com/FBLG2026, seeking approval for electing one Class III director, ratifying WithumSmith+Brown, PC as independent auditor for the year ending December 31, 2026, approving issuance of up to 2,272,728 shares from March 2026 SPA warrants and 159,091 shares from the H.C. Wainwright Engagement Letter, and approving the 2026 Equity and Incentive Compensation Plan. The record date is April 24, 2026, with 5,208,915 common shares outstanding and 125 Series C Preferred shares (held by CEO Pete O’Heeron) providing 1,625,000 votes (~24% of total) via irrevocable proxy to the Board. No financial performance metrics or period-over-period comparisons are disclosed in the filing.

  • ·Annual Meeting record date: April 24, 2026.
  • ·Meeting time: 11:00 a.m. Central Time, virtual only.
  • ·Board recommends FOR all proposals; Series C proxy votes FOR proposals.
  • ·Proxy materials mailed on or about May 5, 2026.
Fabrinet10-Qmixedmateriality 9/10

05-05-2026

Fabrinet reported strong Q3 FY26 results with revenues of $1,214,293 thousand, up 39.3% YoY from $871,799 thousand, net income of $125,213 thousand, up 54.0% YoY, and diluted EPS of $3.45, up 53.3% YoY. For the nine months ended March 27, 2026, revenues reached $3,325,309 thousand, up 32.5% YoY, and net income $333,767 thousand, up 36.1% YoY. However, net cash from operating activities declined 26.1% YoY to $201,758 thousand for the nine months, driven by sharp increases in trade accounts receivable (up $150M) and inventories (up $297M).

  • ·Gross profit margin improved slightly to 11.9% in Q3 FY26 from 11.7% YoY.
  • ·North America revenue represented 52.1% of Q3 total ($633,029 thousand), up from 47.7% for nine months.
  • ·Asia-Pacific and others revenue at 37.4% of Q3 total ($453,881 thousand), down from 42.3% for nine months.
  • ·Europe revenue stable at 10.5% of Q3 total ($127,383 thousand).
  • ·Inventories increased to $875,988 thousand as of March 27, 2026 from $581,015 thousand at June 27, 2025.
  • ·Trade accounts receivable rose to $908,544 thousand from $758,894 thousand.
FibroBiologics, Inc.8-Kneutralmateriality 4/10

05-05-2026

On May 4, 2026, the Compensation Committee of FibroBiologics, Inc. granted stock options under the 2022 Stock Plan to purchase 92,410 shares of common stock to CEO Pete O’Heeron and 61,607 shares each to CFO Jason D. Davis, CSO Hamid Khoja, Ph.D., and General Counsel Ruben A. Garcia, all at an exercise price of $1.38 per share. The options vest with one-fourth on the one-year anniversary of the grant date and the remainder in 36 equal monthly installments thereafter, subject to continued service. No financial performance metrics or period-over-period comparisons were reported.

  • ·Filing date: May 5, 2026; Earliest event date: May 4, 2026
  • ·Registrant is an emerging growth company
  • ·Common stock trades under symbol FBLG on Nasdaq
NFSG Corp13F-HRneutralmateriality 7/10

05-05-2026

NFSG Corp filed its 13F-HR on May 5, 2026, reporting a snapshot of its equity portfolio as of March 31, 2026, with a total value of $608,256,428,000 across 1182 positions, all held on a sole discretionary basis with full voting authority. Top holdings include Apple Inc. at $22,708,308,000 (89,477 shares), Amazon.com Inc. at $21,972,485,000 (105,500 shares), Alphabet Inc. Class C at $14,543,644,000 (50,699 shares), and Broadcom Inc. at $13,902,261,000 (44,917 shares). No period-over-period changes or performance metrics are disclosed in this filing.

  • ·Filing period end date: March 31, 2026
  • ·All positions held as SOLE discretionary with sole voting authority (no other managers)
  • ·SEC file number: 028-21366
  • ·Investment adviser ID: 801-68448
Livforsakringsbolaget Skandia, Omsesidigt13F-HRneutralmateriality 5/10

05-05-2026

Livforsakringsbolaget Skandia, Omsesidigt filed its 13F-HR on May 5, 2026, reporting U.S. equity holdings as of March 31, 2026, with all positions held under sole voting power. Top holdings by market value include Apple Inc. at $25,179,328 (99,268 shares), Amazon.com Inc. at $13,387,161 (64,281 shares), Alphabet Inc. Class A at $11,161,340 (38,818 shares), and Alphabet Inc. Class C at $9,341,989 (32,580 shares). The portfolio spans diverse sectors including technology, finance, and healthcare, with some positions like Baxter International reduced to zero shares.

  • ·Report period end date: March 31, 2026
  • ·All listed holdings (over 300 positions) held with sole voting power and no shared power reported
  • ·Portfolio includes diverse sectors: technology (e.g., Apple, Amazon), communications (e.g., Alphabet, Meta), and financials (e.g., JPMorgan)
Hilton Worldwide Holdings Inc.8-Kneutralmateriality 6/10

05-05-2026

Hilton Worldwide Holdings Inc. announced on May 5, 2026, that Christopher W. Silcock, President, Global Brands & Commercial Services, intends to retire in the first quarter of 2027. In preparation, effective later in 2026, Laura Fuentes will transition to Chief Brand Officer, Chris Wilroy will join the Executive Committee, and the company will conduct an external search for a new Chief Technology Officer.

  • ·Leadership updates effective later in 2026.
  • ·Outside search underway for new Chief Technology Officer.
Amalgamated Financial Corp.10-Qmixedmateriality 8/10

05-05-2026

Amalgamated Financial Corp. reported Q1 2026 net income of $25,223 thousand (up 0.8% YoY from $25,028 thousand), with net interest income growing 13.5% YoY to $80,156 thousand on higher loan ($63,471 thousand) and securities ($44,189 thousand) income. However, provision for credit losses surged to $13,488 thousand from $596 thousand, causing net interest income after provision to decline 4.7% YoY to $66,668 thousand, while non-interest expense rose 10.2% to $45,888 thousand. Total assets expanded 3.4% QoQ to $9,170,892 thousand, driven by 1.3% QoQ growth in net loans receivable to $4,965,203 thousand and 2.9% QoQ increase in deposits to $8,178,084 thousand.

  • ·Earnings per common share - basic: $0.85 (Q1 2026) vs $0.82 (Q1 2025)
  • ·Dividends declared: $0.17 per share (Q1 2026) vs $0.14 per share (Q1 2025)
  • ·Net cash used in investing activities: $387,352 thousand (Q1 2026) vs $6,611 thousand (Q1 2025)
  • ·Accumulated other comprehensive loss increased to $(36,586) thousand from $(32,088) thousand QoQ

Get daily alerts with 12 investment signals, 9 risk alerts, 10 opportunities and full AI analysis of all 50 filings

More from: S&P 500 Consumer Discretionary Sector SEC Filings

🇺🇸 More from United States

View all →